Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery

Atherosclerosis

Volumn 136, Issue 2, 1998, Pages 225-231

  Sakata, Kazuyuki ^a   Miho, Narimasa ^a   Shirotani, Manabu ^a   Yoshida, Hiroshi ^a   Takada, Yumiko ^b   Takada, Akikazu ^b  

^a SHIZUOKA GENERAL HOSPITAL   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Myocardial infarction; Remnant like particle cholesterol; Smoking; Vasospastic angina

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; CORONARY RISK; FAT INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS; CHOLESTEROL; CORONARY VASOSPASM; FEMALE; HUMANS; LIPOPROTEINS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; TRIGLYCERIDES;

EID: 0032007349     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00209-8     Document Type: Article

References (31)

1. Scholl J.M., Benacerraf A., Ducimetiere P., Chabas D., Brau J., Chapelle J., Thery J.L. Comparison of risk factors in vasospastic angina without significant fixed coronary narrowing to significant fixed coronary narrowing and no vasospastic angina. Am J Cardiol. 57:1986;199-202.
2. Sugiishi M., Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 87:1993;76-79.
3. Shirai K., Nii T., Imamura M., Kawano T., Mori T., Nakashima Y., Sasaki J., Arakawa K. Low serum apolipoprotein level in patients with vasospastic angina. Am Heart J. 125:1993;320-323.
4. Tasaki H., Kawashima Y., Nandate H., Yoshiro A., Kawashima T., Kuroiwa A. Comparison of serum lipids values in variant angina pectoris and fixed coronary artery disease with normal subjects. Am J Cardiol. 63:1989;1441-1445.
5. Shinozaki K., Suzuki M., Ikebuchi M., Takaki H., Hara Y., Tsushima M., Harano Y. Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation. 92:1995;1749-1757.
6. Shimabukuro M., Shinzato T., Higa S., Chibana T., Yoshida H., Nagamine F., Murakami K., Takasu N. Enhanced insulin response relates to acetylcholine-induced vasoconstriction in vasospastic angina. J Am Coll Cardiol. 25:1995;356-361.
7. Dahlen G.H., Guyton J.R., Altar M., Farmer J.A., Kautz J.A., Gotto A.M. Association of levels of lipoprotein(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 74:1986;758-765.
8. Steiner G., Schwartz L., Shumak S., Poapst M. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation. 75:1987;124-130.
9. Phillips N.R., Havel R.J. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation. 88:1993;2762-2770.
10. Nakajima K., Saito T., Tamura A., Suzuki M., Nakano T., Adachi M., Tanaka A., Tada N., Nakamura H., Campos E.et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chem Acta. 223:1993;53-71.
11. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470-475.
12. Fossati P., Prencipe L. Serum triglyceride determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 28:1982;2077-2080.
13. Sugiuchi H., Uji Y., Okabe H., Irie T., Uekama K., Kayahara N., Miyauchi K. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated-cyclodextrin. Clin Chem. 41:1995;717-723.
14. Ikeda T., Shibuya Y., Senba U.H., Sugiuchi H., Araki S., Uji Y., Okabe H. Automated immunoturbidimetric analysis of six plasma apolipoproteins: Correlation with radial immunodiffusion assays. J Clin Lab Anal. 5:1991;90-95.
15. Friedewald W.T., Levy R.I., Frederickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-508.
16. Brasdstrom A., Johnson O., Dahlen G., Randy M. Lp(a) levels in a healthy population measured by a new enzyme linked immunoabsorbent assay. Thromb Haemost. 62:1989;573-577.
17. Tashiro H., Shimokawa H., Koyanagi S., Takeshita A. Clinical characteristics of patients with spontaneous remission of variant angina. Jpn Circ J. 57:1993;117-122.
18. Maouad J., Fernandez F., Barillon A., Gerbaux A., Gay J. Diffuse or segmental narrowing (spasm) of the coronary arteries during smoking demonstrated on angiography. Am J Cardiol. 53:1984;354-355.
19. Kannel W.B. Update on the role of cigarette smoking in coronary artery disease. Am Heart J. 101:1981;319-328.
20. Yasue H., Matsuyama K., Okumura K., Morikami Y., Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: possible role of early coronary atherosclerosis. Circulation. 81:1990;482-490.
21. Roheim P.S. Atherosclerosis and lipoprotein metabolism: role of reverse cholesterol transport. Am J Cardiol. 57:1986;3C-10C.
22. Maciejko J.J., Holmes D.R., Kottke B.A., Zinsmeister A.R., Dinh D.M., Mao S.I.T. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. New Eng J Med. 309:1983;385-389.
23. Yui Y., Aoyama T., Morishita H., Takahashi M., Takatsu Y., Kawai C. Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (apo A-I), A novel function of apo A-1. J Clin Invest. 82:1988;803-807.
24. Steiner G. Endogenous hypertriglyceridemia. In: Steiner G, Shafrir E, editors. Primary Hyperlipoproteinemias. New York: McGraw-Hill, 1991:195-200.
25. Mehta J., Mehta P., Lawson D., Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations. J Am Coll Cardiol. 9:1987;263-268.
26. Simpson H.C.R., Mann J.I., Meade T.W., Ohakrabarti R., Stirling Y., Woolf L. Hypertriglyceridemia and hypercoagulability. Lancet. i:1983;786-789.
27. Stiko-Rahm A., Wiman B., Hamsten A., Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis. 10:1990;1067-1073.
28. Knofler R., Nakano T., Nakajima K., Takada Y., Takada A. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. Thromb Res. 78:1995;161-171.
29. Yasue H., Takizawa A., Nagao M., Nishida S., Horie M., Kubota J., Omote S., Takaoka K., Okumura K. Long-term prognosis for patients with variant angina and influential factors. Circulation. 78:1988;1-9.
30. Nakamura M., Takeshita A., Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation. 75:1987;1110-1116.
31. Mochizuki M., Takada Y., Urano T., Nagai N., Nakano T., Nakajima K., Takada A. The in vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons. Thomb Res. 81:1996;583-594.